Article
A Plasma Metabolomic Signature Involving Purine Metabolism in Human Optic Atrophy 1 (OPA1)-Related Disorders.
Investigative ophthalmology & visual science - 1 Jan 2018
Bocca Cinzia, Kouassi Nzoughet Judith, Leruez Stéphanie, Amati-Bonneau Patrizia, Ferré Marc, Kane Mariame-Selma, Veyrat-Durebex Charlotte, Chao de la Barca Juan Manuel, Chevrollier Arnaud, Homedan Chadi, Verny Christophe, Miléa Dan, Procaccio Vincent, Simard Gilles, Bonneau Dominique, Lenaers Guy, Reynier Pascal
Abstract excerpt
Purpose: Dominant optic atrophy (DOA; MIM [Mendelian Inheritance in Man] 165500), resulting in retinal ganglion cell degeneration, is mainly caused by mutations in the optic atrophy 1 (OPA1) gene, which encodes a dynamin guanosine triphosphate (GTP)ase involved in mitochondrial membrane processing. This work aimed at determining whether plasma from OPA1 pathogenic variant carriers displays a specific metabolic...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
